Quantitative assessment of clinical disease status in primary Sjogren's syndrome - A cross-sectional study using a new classification model

被引:20
作者
Asmussen, K
Andersen, V
Bendixen, G
Bendtzen, K
Prause, JU
Thorn, J
Wiik, A
Oxholm, P
机构
[1] NATL UNIV HOSP,RIGSHOSP,DEPT MED TA,DIV RHEUMATOL & MED IMMUNOL,COPENHAGEN,DENMARK
[2] NATL UNIV HOSP,RIGSHOSP,DEPT OPHTHALMOL,COPENHAGEN,DENMARK
[3] NATL UNIV HOSP,RIGSHOSP,DEPT ORAL SURG,COPENHAGEN,DENMARK
[4] NATL UNIV HOSP,RIGSHOSP,INST INFLAMMAT RES,COPENHAGEN,DENMARK
[5] STATE SERUM INST,DEPT AUTOIMMUINOL,COPENHAGEN,DENMARK
关键词
Sjogren's syndrome; terminology; classification criteria; status indices; immunoinflammation; cytokines;
D O I
10.3109/03009749709065681
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Quantitative and qualitative assessment of the clinical disease manifestations in 41 primary Sjogren's syndrome (pSS) patients was performed according to a new classification model. Frequencies of subgrouped disease manifestations were as follows: 1) surface exocrine disease: 100%, 2) internal organ exocrine disease: 63%, 3) monoclonal B lymphocyte disease: 5%, 4) inflammatory vascular disease: 71%, 5) non-inflammatory vascular disease: 59%, 6) mediator induced disease: 98%. Summary scores for severity of surface exocrine disease correlated to the summary scores of all other disease manifestations (p=0.02), to the summary scores of internal organ exocrine disease (p=0.003), and to the summary scores of mediator induced disease (p=0.03). Blood leucocyte counts showed significant negative correlations to levels of plasma IgG, serum IgA-RF, IgM-RF, anti-SSA/SSB antibodies, IL-6, and IL-1Ra. We conclude that the model made detailed analysis of the clinical presentation of pSS possible, and thus may assist in elucidating important pathobiological aspect of the disease.
引用
收藏
页码:197 / 205
页数:9
相关论文
共 32 条
[1]   A new model for classification of disease manifestations in primary Sjogren's syndrome: Evaluation in a retrospective long-term study [J].
Asmussen, K ;
Andersen, V ;
Bendixen, G ;
Schiodt, M ;
Oxholm, P .
JOURNAL OF INTERNAL MEDICINE, 1996, 239 (06) :475-482
[2]  
ASMUSSEN K, 1994, CLIN EXP RHEUMAT S11, V12, pS91
[3]  
BARENDREGT PJ, 1995, CLIN RHEUMATOL S1, V14, P51
[4]  
FOX RI, 1992, RHEUM DIS CLIN N AM, V18, P517
[5]  
FOX RI, 1994, J IMMUNOL, V152, P5532
[6]   HUMAN ANTI-INTERLEUKIN-1-ALPHA ANTIBODIES [J].
HANSEN, MB ;
SVENSON, M ;
BENDTZEN, K .
IMMUNOLOGY LETTERS, 1991, 30 (01) :133-140
[7]   SUBCLINICAL LUNG INFLAMMATION IN PRIMARY SJOGRENS-SYNDROME - RELATIONSHIP BETWEEN BRONCHOALVEOLAR LAVAGE CELLULAR ANALYSIS FINDINGS AND CHARACTERISTICS OF THE DISEASE [J].
HATRON, PY ;
WALLAERT, B ;
GOSSET, D ;
TONNEL, AB ;
GOSSELIN, B ;
VOISIN, CYR ;
DEVULDER, B .
ARTHRITIS AND RHEUMATISM, 1987, 30 (11) :1226-1231
[8]   SANDWICH ELISA FORMATS DESIGNED TO DETECT 17 KDA IL-1-BETA SIGNIFICANTLY UNDERESTIMATE 35 KDA IL-1-BETA [J].
HERZYK, DJ ;
BERGER, AE ;
ALLEN, JN ;
WEWERS, MD .
JOURNAL OF IMMUNOLOGICAL METHODS, 1992, 148 (1-2) :243-254
[9]  
HOMMA M, 1994, SJOGRENS SYNDDROME S
[10]  
ICHIKAWA Y, 1981, Tokai Journal of Experimental and Clinical Medicine, V6, P11